Table 1.

Characteristics of the CUtLASS cognitive study sample at trial entry

	Mean (SD)	Range
Age (years)	41.9 (12.0)	22–67
Duration of illness (years)	16.5 (12.0)	1–46
PANSS Positive symptoms	16.6 (6.92)	7–37
PANSS Negative symptoms	22.0 (7.58)	7–42
PANSS General symptoms	34.5 (8.66)	7–56
Global Assessment of Function	43.3 (15.0)	17–66
NART premorbid IQ	105.6 (12.3)	87–123
Drug allocations	FGA (n)	SGA (n)
	Droperidol (1)	Clozapine (14)
	Haloperidol (2)	Quetiapine (4)
	Sulpiride (10)	Risperidone (4)
	Thioridazine (1)	Olanzapine (19)
	Trifluoperazine (2)
	Zuclopenthixol (1)